TF and neoplasm: The outcomes exhibited by transferrin surface modified liposomes increased the delivery of both drugs and inhibited multidrug resistance, extended half-life, higher intracellular uptake, reduced malignancy, decreased non-specific bio-distribution observed in tumour-bearing mice.